← FDA Drug Approvals (Drugs@FDA)
ATOVAQUONE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2017-10-11
Drug application
- FDA Application #
ANDA209750- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- ATOVAQUONE
- Generic name
- Atovaquone
- Active ingredients
- ATOVAQUONE
- Dosage form
- SUSPENSION
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- APOTEX
- First approval
- 2017-10-11
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown